Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S et al (2020) Time to diagnosis in Cushing’s syndrome: a meta-analysis based on 5367 patients. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgz136

Article  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9:847–875

Article  PubMed  PubMed Central  Google Scholar 

Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39:440–488

Article  PubMed  Google Scholar 

Giuliodori A, Soudah E, Malouf J, Martel-Duguech L, Amodru V, Gil J et al (2024) Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing’s syndrome using quantitative computed tomography–based finite element analysis. Eur J Endocrinol 190:86–95

Article  PubMed  Google Scholar 

Valassi E (2022) Clinical presentation and etiology of Cushing’s syndrome: data from ERCUSYN. J Neuroendocrinol. https://doi.org/10.1111/jne.13114

Article  PubMed  Google Scholar 

Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M et al (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing’s disease: a prospective study. Clin Endocrinol (Oxf) 58:302–308

Article  PubMed  Google Scholar 

Ohmori N, Nomura K, Ohmori K, Kato Y, Itoh T, Takano K (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing’s syndrome. Endocr J 50:1–7

Article  PubMed  Google Scholar 

Tauchmanovà L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L et al (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779–1784

Article  PubMed  Google Scholar 

Trementino L, Appolloni G, Ceccoli L, Marcelli G, Concettoni C, Boscaro M et al (2014) Bone complications in patients with Cushing’s syndrome: looking for clinical, biochemical, and genetic determinants. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 25:913–921

Article  CAS  Google Scholar 

Zhou H, Cooper MS, Seibel MJ (2013) Endogenous Glucocorticoids and Bone Bone Res 1:107–119

CAS  PubMed  Google Scholar 

Gado M, Baschant U, Hofbauer LC, Henneicke H (2022) Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes. Front Endocrinol. https://doi.org/10.3389/fendo.2022.835720/full

Article  Google Scholar 

Lane NE (2019) Glucocorticoid-induced osteoporosis: new insights into the pathophysiology and treatments. Curr Osteoporos Rep 17:1–7

Article  PubMed  PubMed Central  Google Scholar 

Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A (2022) Novel approaches to bone comorbidity in Cushing’s disease: an update. Pituitary 25:754–759

Article  PubMed  Google Scholar 

Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ (2001) Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res Off J Am Soc Bone Miner Res 16:97–103

Article  CAS  Google Scholar 

Belaya ZE, Grebennikova TA, Melnichenko GA, Nikitin AG, Solodovnikov AG, Brovkina OI et al (2018) Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 29:211–221

Article  CAS  Google Scholar 

van Lierop AH, van der Eerden AW, Hamdy NT, Hermus AR, den Heijer M, Papapoulos SE (2012) Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. J Clin Endocrinol Metab 97:1953–1957

Article  Google Scholar 

Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schüler C, Stolina M et al (2009) Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum 60:1427–1437

Article  PubMed  Google Scholar 

Yao W, Dai W, Jiang JX, Lane NE (2013) Glucocorticoids and osteocyte autophagy. Bone 54:279–284

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab TEM 34:231–242

Article  CAS  PubMed  Google Scholar 

Kim SM, Sultana F, Korkmaz F, Lizneva D, Yuen T, Zaidi M (2022) Independent skeletal actions of pituitary hormones. Endocrinol Metab 37:719–731

Article  CAS  Google Scholar 

Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M (2004) Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing’s syndrome. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 15:855–861

Article  CAS  Google Scholar 

Belaya ZE, Hans D, Rozhinskaya LY, Dragunova NV, Sasonova NI, Solodovnikov AG et al (2015) The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing’s syndrome. Arch Osteoporos. https://doi.org/10.1007/s11657-015-0244-1

Article  PubMed  Google Scholar 

Martel-Duguech L, Alonso-Jiménez A, Bascuñana H, Díaz-Manera J, Llauger J, Nuñez-Peralta C et al (2020) Thigh muscle fat infiltration is associated with impaired physical performance despite remission in Cushing’s syndrome. J Clin Endocrinol Metab 105:2039–2049

Article  Google Scholar 

Vogel F, Braun LT, Rubinstein G, Zopp S, Künzel H, Strasding F et al (2020) Persisting muscle dysfunction in Cushing’s syndrome despite biochemical remission. J Clin Endocrinol Metab 105(12):e4490–e4498

Article  PubMed  PubMed Central  Google Scholar 

Amodru V, Ferriere A, Tabarin A, Castinetti F, Tsagarakis S, Toth M et al (2023) Cushing’s syndrome in the elderly: data from the European Registry on Cushing’s syndrome. Eur J Endocrinol 188(4):395–406

Article  PubMed  Google Scholar 

Vogel F, Braun L, Rubinstein G, Zopp S, Benedix S, Schneider H et al (2021) Patients with low IGF-I after curative surgery for Cushing’s syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy. Eur J Endocrinol 184:813–821

Article  CAS  PubMed  Google Scholar 

Mazziotti G, Formenti AM, Adler RA, Bilezikian JP, Grossman A, Sbardella E et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine 54:603–611

Article  CAS  PubMed  Google Scholar 

Formenti AM, Maffezzoni F, Doga M, Mazziotti G, Giustina A (2017) Growth hormone deficiency in treated acromegaly and active Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 31:79–90

Article  CAS  PubMed  Google Scholar 

Mazziotti G, Doga M, Frara S, Maffezzoni F, Porcelli T, Cerri L et al (2016) Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine 52:103–110

Article  CAS  PubMed  Google Scholar 

Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, Colao A (2016) Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol 4:611–629

Article  CAS  PubMed  Google Scholar 

Johannsson G, Sunnerhagen KS, Svensson J (2004) Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing’s disease. Clin Endocrinol (Oxf) 60:550–559

Article  CAS  PubMed  Google Scholar 

Scommegna S, Greening JP, Storr HL, Davies KM, Shaw NJ, Monson JP et al (2005) Bone mineral density at diagnosis and following successful treatment of pediatric Cushing’s disease. J Endocrinol Invest 28:231–235

Article  CAS  PubMed  Google Scholar 

van Varsseveld NC, van Bunderen CC, Franken AM, Koppeschaar HPF, van der Lely AJ, Drent ML (2016) Fractures in pituitar